Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen‐receptor–targeted therapy for metastatic castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen‐receptor–targeted therapy for metastatic castration‐resistant prostate cancer

Published:2021-04-02 Issue:14 Volume:127 Page:2587-2594
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Alibhai Shabbir M. H.¹²³^ORCID,Breunis Henriette¹,Hansen Aaron R.¹²^ORCID,Gregg Richard⁴,Warde Padraig⁵,Timilshina Narhari¹,Tomlinson George¹³⁶,Joshua Anthony M.¹⁷,Hotte Sebastien⁸,Fleshner Neil⁹,Emmenegger Urban¹⁰

Affiliation:

1. Department of Medicine University Health Network Toronto Ontario Canada

2. Department of Medicine University of Toronto Toronto Ontario Canada

3. Institute of Health Policy, Management, and Evaluation University of Toronto Toronto Ontario Canada

4. Department of Medical Oncology Kingston Health Sciences Centre Kingston Ontario Canada

5. Radiation Medicine Program University Health Network Toronto Ontario Canada

6. Biostatistics Research Unit University Health Network Toronto Ontario Canada

7. Kinghorn Cancer Centre University of New South Wales Sydney New South Wales Australia

8. Juravinski Cancer Centre Hamilton Ontario Canada

9. Division of Urology University Health Network Toronto Ontario Canada

10. Department of Medicine Sunnybrook Health Sciences Centre Toronto Ontario Canada

Funder

Prostate Cancer Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33523

Reference29 articles.

1. Cancer statistics, 2015

2. Treatment of mCRPC in the AR-axis-targeted therapy-resistant state

3. Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

4. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

5. Metastatic Prostate Cancer

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The applicability of the Cancer and Aging Research Group (CARG) chemotherapy toxicity prediction tool;Journal of Geriatric Oncology;2024-09

2. Geriatric assessment for the practicing clinician: The why, what, and how;CA: A Cancer Journal for Clinicians;2024-08-29

3. TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluation;Journal of Geriatric Oncology;2024-07

4. Assessing the ability of the Cancer and Aging Research Group tool to predict chemotherapy toxicity in older Japanese patients: A prospective observational study;Journal of Geriatric Oncology;2024-07

5. Outcomes in studies regarding older patients with prostate cancer: A systematic review;Journal of Geriatric Oncology;2024-06